KR20080052585A - 올리고뉴클레오티드 디자인 및/또는 핵산 탐지 방법및/또는 장치 - Google Patents
올리고뉴클레오티드 디자인 및/또는 핵산 탐지 방법및/또는 장치 Download PDFInfo
- Publication number
- KR20080052585A KR20080052585A KR1020087006089A KR20087006089A KR20080052585A KR 20080052585 A KR20080052585 A KR 20080052585A KR 1020087006089 A KR1020087006089 A KR 1020087006089A KR 20087006089 A KR20087006089 A KR 20087006089A KR 20080052585 A KR20080052585 A KR 20080052585A
- Authority
- KR
- South Korea
- Prior art keywords
- nucleic acid
- target nucleic
- oligonucleotide
- probe
- probes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 334
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 301
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 301
- 108091034117 Oligonucleotide Proteins 0.000 title claims abstract description 120
- 238000001514 detection method Methods 0.000 title claims abstract description 100
- 238000013461 design Methods 0.000 title claims description 60
- 239000000523 sample Substances 0.000 claims abstract description 498
- 238000000034 method Methods 0.000 claims abstract description 209
- 241000700605 Viruses Species 0.000 claims abstract description 139
- 244000052769 pathogen Species 0.000 claims abstract description 132
- 239000012472 biological sample Substances 0.000 claims abstract description 101
- 230000003321 amplification Effects 0.000 claims abstract description 100
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 100
- 230000001717 pathogenic effect Effects 0.000 claims abstract description 90
- 238000002493 microarray Methods 0.000 claims abstract description 82
- 230000000694 effects Effects 0.000 claims abstract description 25
- 238000009826 distribution Methods 0.000 claims description 87
- 238000009396 hybridization Methods 0.000 claims description 69
- 230000002441 reversible effect Effects 0.000 claims description 52
- 238000000692 Student's t-test Methods 0.000 claims description 42
- 238000012353 t test Methods 0.000 claims description 42
- 238000003556 assay Methods 0.000 claims description 36
- 238000003757 reverse transcription PCR Methods 0.000 claims description 33
- 239000002773 nucleotide Substances 0.000 claims description 32
- 125000003729 nucleotide group Chemical group 0.000 claims description 32
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 26
- 239000002751 oligonucleotide probe Substances 0.000 claims description 26
- 239000012634 fragment Substances 0.000 claims description 25
- 230000001186 cumulative effect Effects 0.000 claims description 17
- 230000027455 binding Effects 0.000 claims description 16
- 238000005315 distribution function Methods 0.000 claims description 16
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 13
- 244000045947 parasite Species 0.000 claims description 13
- 238000003860 storage Methods 0.000 claims description 11
- 238000004590 computer program Methods 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000010200 validation analysis Methods 0.000 claims description 2
- 208000003322 Coinfection Diseases 0.000 claims 2
- 239000013615 primer Substances 0.000 description 163
- 241000725643 Respiratory syncytial virus Species 0.000 description 83
- 238000002474 experimental method Methods 0.000 description 42
- 230000003612 virological effect Effects 0.000 description 35
- 238000004422 calculation algorithm Methods 0.000 description 34
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 25
- 208000001490 Dengue Diseases 0.000 description 25
- 206010012310 Dengue fever Diseases 0.000 description 25
- 208000025729 dengue disease Diseases 0.000 description 25
- 206010035664 Pneumonia Diseases 0.000 description 23
- 238000004458 analytical method Methods 0.000 description 19
- 238000010839 reverse transcription Methods 0.000 description 19
- 241000711573 Coronaviridae Species 0.000 description 18
- 238000012360 testing method Methods 0.000 description 14
- 230000008569 process Effects 0.000 description 13
- 238000000767 Anderson–Darling test Methods 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 241000710831 Flavivirus Species 0.000 description 10
- 239000013610 patient sample Substances 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 10
- 241001428935 Human coronavirus OC43 Species 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 9
- 239000013642 negative control Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 238000000018 DNA microarray Methods 0.000 description 8
- 241000713196 Influenza B virus Species 0.000 description 8
- 239000000539 dimer Substances 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 241000712431 Influenza A virus Species 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 238000000126 in silico method Methods 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 6
- 238000003491 array Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 6
- 208000002672 hepatitis B Diseases 0.000 description 6
- 201000005404 rubella Diseases 0.000 description 6
- 241000315672 SARS coronavirus Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 241000709661 Enterovirus Species 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 208000005252 hepatitis A Diseases 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 3
- 241000351643 Metapneumovirus Species 0.000 description 3
- 208000003152 Yellow Fever Diseases 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000010460 detection of virus Effects 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 208000037797 influenza A Diseases 0.000 description 3
- 208000037798 influenza B Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000988559 Enterovirus A Species 0.000 description 2
- 241000988556 Enterovirus B Species 0.000 description 2
- 241000991587 Enterovirus C Species 0.000 description 2
- 241000991586 Enterovirus D Species 0.000 description 2
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 2
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 2
- 241000711467 Human coronavirus 229E Species 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- 241000711920 Human orthopneumovirus Species 0.000 description 2
- 241000340975 Human papillomavirus type 10 Species 0.000 description 2
- 241000710842 Japanese encephalitis virus Species 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 241000233803 Nypa Species 0.000 description 2
- 235000005305 Nypa fruticans Nutrition 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000709664 Picornaviridae Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000003050 axon Anatomy 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 244000052613 viral pathogen Species 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 1
- 241000712891 Arenavirus Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 241000710827 Dengue virus 1 Species 0.000 description 1
- 241000710815 Dengue virus 2 Species 0.000 description 1
- 241000710872 Dengue virus 3 Species 0.000 description 1
- 241000710844 Dengue virus 4 Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000709721 Hepatovirus A Species 0.000 description 1
- 241000342334 Human metapneumovirus Species 0.000 description 1
- 241001128035 Human parainfluenza virus 1 strain Washington/1964 Species 0.000 description 1
- 241001244458 Human respiratory syncytial virus B Species 0.000 description 1
- 241000712003 Human respirovirus 3 Species 0.000 description 1
- 241001559187 Human rubulavirus 2 Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000726306 Irus Species 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241001424413 Lucia Species 0.000 description 1
- 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- SHGAZHPCJJPHSC-UHFFFAOYSA-N Panrexin Chemical compound OC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000882890 Renova Species 0.000 description 1
- 241000649112 SARS coronavirus Sin2500 Species 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000013412 genome amplification Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229940059527 renova Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012508 resin bead Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B99/00—Subject matter not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medical Informatics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/202,023 | 2005-08-12 | ||
| US11/202,023 US20070042388A1 (en) | 2005-08-12 | 2005-08-12 | Method of probe design and/or of nucleic acids detection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20080052585A true KR20080052585A (ko) | 2008-06-11 |
Family
ID=37757981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020087006089A Ceased KR20080052585A (ko) | 2005-08-12 | 2006-08-08 | 올리고뉴클레오티드 디자인 및/또는 핵산 탐지 방법및/또는 장치 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20070042388A1 (enExample) |
| EP (1) | EP1922418A4 (enExample) |
| JP (1) | JP2009504153A (enExample) |
| KR (1) | KR20080052585A (enExample) |
| CN (1) | CN101292044B (enExample) |
| AU (1) | AU2006280489B2 (enExample) |
| WO (1) | WO2007021250A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102020614B1 (ko) * | 2018-09-11 | 2019-09-11 | 한국과학기술정보연구원 | 결핵 진단용 프라이머 세트 및 이의 용도 |
| WO2020054906A1 (ko) * | 2018-09-11 | 2020-03-19 | 한국과학기술정보연구원 | 목표 유전자를 검출하기 위한 프라이머의 설계 방법 |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101138864B1 (ko) * | 2005-03-08 | 2012-05-14 | 삼성전자주식회사 | 프라이머 및 프로브 세트를 설계하는 방법, 그에 의하여 설계된 프라이머 및 프로브 세트, 상기 세트를 포함하는 키트, 상기 방법을 컴퓨터가 수행할 수 있도록 하는 프로그램을기록한 컴퓨터 판독가능한 매체 및 상기 세트를 이용한 표적 서열의 동정 방법 |
| US20070042388A1 (en) * | 2005-08-12 | 2007-02-22 | Wong Christopher W | Method of probe design and/or of nucleic acids detection |
| US20100159533A1 (en) * | 2008-11-24 | 2010-06-24 | Helicos Biosciences Corporation | Simplified sample preparation for rna analysis |
| WO2011046614A2 (en) * | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods and systems for phylogenetic analysis |
| US20110152109A1 (en) * | 2009-12-21 | 2011-06-23 | Gardner Shea N | Biological sample target classification, detection and selection methods, and related arrays and oligonucleotide probes |
| WO2012173636A1 (en) * | 2011-06-16 | 2012-12-20 | University Of Rochester | Hiv incidence assays with high sensitivity and specificity |
| JP5756247B1 (ja) | 2012-05-08 | 2015-07-29 | アダプティブ バイオテクノロジーズ コーポレイション | マルチプレックスｐｃｒ反応における増幅バイアスを測定し校正する組成物及び方法 |
| CN105780129B (zh) * | 2014-12-15 | 2019-06-11 | 天津华大基因科技有限公司 | 目标区域测序文库构建方法 |
| US11319602B2 (en) | 2017-02-07 | 2022-05-03 | Tcm Biotech Internationl Corp. | Probe combination for detection of cancer |
| US10787699B2 (en) * | 2017-02-08 | 2020-09-29 | Microsoft Technology Licensing, Llc | Generating pluralities of primer and payload designs for retrieval of stored nucleotides |
| JP6995604B2 (ja) * | 2017-12-15 | 2022-01-14 | 東洋鋼鈑株式会社 | 一塩基多型検出用プローブの設計方法及びプローブセット |
| CN109097450B (zh) * | 2018-08-30 | 2022-05-13 | 江苏省疾病预防控制中心 | 一种核酸序列非依赖的全rna扩增方法 |
| CN115101128B (zh) * | 2022-06-29 | 2023-09-15 | 纳昂达(南京)生物科技有限公司 | 一种杂交捕获探针脱靶危险性评估的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000194554A (ja) * | 1998-12-25 | 2000-07-14 | Nec Corp | 演算処理装置 |
| US20030096986A1 (en) * | 2001-10-25 | 2003-05-22 | Affymetrix, Incorporated | Methods and computer software products for selecting nucleic acid probes |
| GB2377017A (en) * | 2001-06-28 | 2002-12-31 | Animal Health Inst | Detection of foot and mouth disease virus |
| JP3980030B2 (ja) * | 2002-08-12 | 2007-09-19 | 株式会社日立ハイテクノロジーズ | Ｄｎａマイクロアレイを用いた核酸検出方法及び核酸検出装置 |
| US20040259124A1 (en) * | 2003-02-19 | 2004-12-23 | Affymetrix, Inc. | Methods for oligonucleotide probe design |
| US20070042388A1 (en) * | 2005-08-12 | 2007-02-22 | Wong Christopher W | Method of probe design and/or of nucleic acids detection |
-
2005
- 2005-08-12 US US11/202,023 patent/US20070042388A1/en not_active Abandoned
-
2006
- 2006-08-08 KR KR1020087006089A patent/KR20080052585A/ko not_active Ceased
- 2006-08-08 EP EP06769707A patent/EP1922418A4/en not_active Withdrawn
- 2006-08-08 CN CN2006800369768A patent/CN101292044B/zh not_active Expired - Fee Related
- 2006-08-08 JP JP2008525967A patent/JP2009504153A/ja active Pending
- 2006-08-08 US US11/990,290 patent/US8234079B2/en not_active Expired - Fee Related
- 2006-08-08 WO PCT/SG2006/000224 patent/WO2007021250A2/en not_active Ceased
- 2006-08-08 AU AU2006280489A patent/AU2006280489B2/en not_active Ceased
-
2012
- 2012-07-13 US US13/549,032 patent/US20120309643A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102020614B1 (ko) * | 2018-09-11 | 2019-09-11 | 한국과학기술정보연구원 | 결핵 진단용 프라이머 세트 및 이의 용도 |
| WO2020054906A1 (ko) * | 2018-09-11 | 2020-03-19 | 한국과학기술정보연구원 | 목표 유전자를 검출하기 위한 프라이머의 설계 방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009504153A (ja) | 2009-02-05 |
| EP1922418A4 (en) | 2010-02-03 |
| EP1922418A2 (en) | 2008-05-21 |
| US20090053708A1 (en) | 2009-02-26 |
| WO2007021250A3 (en) | 2007-07-05 |
| WO2007021250A2 (en) | 2007-02-22 |
| US20070042388A1 (en) | 2007-02-22 |
| CN101292044A (zh) | 2008-10-22 |
| AU2006280489A1 (en) | 2007-02-22 |
| CN101292044B (zh) | 2012-11-07 |
| US20120309643A1 (en) | 2012-12-06 |
| AU2006280489B2 (en) | 2012-05-24 |
| US8234079B2 (en) | 2012-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20120309643A1 (en) | Method and/or apparatus of oligonucleotide design and/or nucleic acid detection | |
| US10047397B2 (en) | Breast cancer associated circulating nucleic acid biomarkers | |
| US8232058B2 (en) | Multiplex detection of respiratory pathogens | |
| Wong et al. | Optimization and clinical validation of a pathogen detection microarray | |
| US20080003565A1 (en) | Viral nucleic acid microarray and method of use | |
| CN104017908B (zh) | 人乳头状瘤病毒的快速基因型鉴定分析及其装置 | |
| JP2013531983A (ja) | 多重生物検出のための核酸ならびにその使用および製造方法 | |
| US11739374B2 (en) | Methods and compositions for pathogen detection in plants | |
| US20230193410A1 (en) | Identification of nsp1 gene as target of sars-cov-2 real-time rt-pcr using nanopore whole genome sequencing | |
| US20050136395A1 (en) | Methods for genetic analysis of SARS virus | |
| US20220042117A1 (en) | COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) | |
| JP2023519919A (ja) | 病原体を検出するためのアッセイ | |
| RU2478718C2 (ru) | Способ обнаружения респираторных вирусных агентов в образце | |
| CN115917002A (zh) | 病原体诊断测试 | |
| CN112981007A (zh) | 一种检测汉滩型汉坦病毒的试剂盒及其检测方法 | |
| US20170022573A1 (en) | Compositions and Methods for Metagenome Biomarker Detection | |
| US20230383368A1 (en) | A detection method for viral replication | |
| JP2011239708A (ja) | 核酸標準物質検出用プローブの設計方法、核酸標準物質検出用プローブ及び当該核酸標準物質検出用プローブを有する核酸検出系 | |
| US20230295749A1 (en) | Methods and systems for detecting and discriminating between viral variants | |
| Jabado et al. | Nonparametric methods for the analysis of single-color pathogen microarrays | |
| WO2025049770A1 (en) | <u style="single">CHARACTERIZING DENGUE VIRUS | |
| KR101058820B1 (ko) | 유전자 서열 분석용 다중 중합효소 연쇄 반응 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20080312 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20100402 Comment text: Request for Examination of Application |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20111027 Patent event code: PE09021S01D |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20120827 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20121228 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20120827 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 20111027 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |